ReviewAIDS research and human retroviruses2020

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.

Marta Boffito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.